Clinical trial

Enteral Glutamine in Critical Illness

NCT00318331 · Christiana Care Health Services, Other · Terminated

Key facts

NCT number NCT00318331
Title Enteral Glutamine in Critical Illness
Official title Randomized Clinical Trial Comparing Enteral Glutamine Supplementation to Standard of Care Enteral Feeding in Critical Illness
Lead sponsor Christiana Care Health Services, Other
Status Terminated
Phase Phase 2/Phase 3
Study type Interventional
Conditions Critical Illness, Sepsis, Respiratory Insufficiency
Intervention type Drug
Interventions Glutamine
Enrollment 20
Start date May 1, 2006
Primary completion Sep 1, 2007
Completion Sep 1, 2007
First posted Apr 26, 2006
Last update posted Mar 13, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies